Your session is about to expire
← Back to Search
High-frequency repetitive transcranial magnetic stimulation for Spinal Cord Injury (rTMS Trial)
rTMS Trial Summary
This trial is testing a new treatment for spinal cord injury using magnetic stimulation. The goal is to see if it is safe and effective.
rTMS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.rTMS Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Am I eligible to volunteer for this clinical investigation?
"At this time, the clinical trial is open to those aged 18-55 who have been diagnosed with an incomplete spinal cord injury between C2 and C6 levels of the spine. Outpatients must have experienced their damage for at least 6 months; inpatient injuries cannot be more than 8 weeks old. In addition, patients' diagnoses must fulfill grade A, B, C or D criteria set by the American Spinal Injury Association's Impairment Scale."
What is the aggregate participation in this medical experiment?
"Yes, the data on clinicaltrials.gov confirms that this research project is currently recruiting participants. It was first released on August 20th 2022 and most recently updated October 12th of the same year. The trial seeks to enrol a total of 20 patients from one medical centre."
Are there any opportunities for enrollment in this experiment?
"Clinicaltrials.gov confirms that this clinical trial, which was initiated on August 20th 2022 is actively looking for participants. The research study's details were last modified on October 12th 2022."
Are participants of this experiment restricted to individuals aged 20 or younger?
"The age range criteria for this medical study necessitates that participants are between 18 to 55 years old. In contrast, there exists 37 trials specifically designed for the under-eighteens and 307 studies centered around those aged 65+."
Share this study with friends
Copy Link
Messenger